Clinical Trials Browser

Interventional × Estrogen Receptor-positive Breast Cancer × Fulvestrant × Clear all

NCT03633331 2021-10-15

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

Phase 2 Unknown

93 enrolled 8 charts

Estrogen Receptor-positive Breast Cancer

NCT05076695 2021-10-13

NeoTPPF

Phase 2 Unknown

Estrogen Receptor-positive Breast Cancer